N00.7 Acute nephritic syndrome with diffuse crescentic glomerulonephritis

Name of the Condition

• Acute Nephritic Syndrome with Diffuse Crescentic Glomerulonephritis
• ICD-10 Code: N00.7

Summary

Acute nephritic syndrome with diffuse crescentic glomerulonephritis is a severe kidney disorder characterized by rapid inflammation and damage to the glomeruli, the kidney's filtering units. This condition involves widespread crescent formation in the glomeruli, leading to impaired kidney function, hematuria (blood in urine), proteinuria (excess protein in urine), and hypertension. It requires urgent medical intervention due to its potential for rapid progression to kidney failure.

Causes

The condition is typically triggered by immune-mediated processes, such as autoimmune reactions or infections, that cause severe inflammation in the glomeruli. Common triggers include systemic vasculitis, anti-glomerular basement membrane disease, or post-infectious responses. In some cases, the exact cause remains idiopathic (unknown).

Risk Factors

• Autoimmune conditions: Diseases like systemic lupus erythematosus or granulomatosis with polyangiitis.
• Infections: Recent bacterial or viral infections that may trigger immune responses.
• Genetic predisposition: Family history of kidney disease or autoimmune disorders.
• Environmental exposures: Certain medications or toxins that can induce glomerular injury.

Symptoms

• Hematuria (visible or microscopic blood in urine).
• Proteinuria (foamy or frothy urine).
• Edema (swelling in the face, hands, or legs).
• Hypertension (high blood pressure).
• Oliguria (reduced urine output).
• Fatigue or malaise.

Diagnosis

Diagnosis involves urinalysis to detect blood and protein, blood tests to assess kidney function (e.g., creatinine, BUN), and imaging studies (e.g., ultrasound) to evaluate kidney structure. A definitive diagnosis often requires a kidney biopsy to identify crescentic glomerulonephritis and rule out other causes.

Treatment Options

Treatment focuses on reducing inflammation and preserving kidney function. This may include immunosuppressive medications (e.g., corticosteroids, cyclophosphamide), plasma exchange (plasmapheresis) for severe cases, and supportive care (e.g., blood pressure management, diuretics). In advanced cases, dialysis or kidney transplantation may be necessary.

Prognosis and Follow-Up

Prognosis varies depending on the underlying cause and timeliness of treatment. Early intervention improves outcomes, but some patients may progress to chronic kidney disease or end-stage renal failure. Regular follow-up with kidney function monitoring and blood pressure checks is essential to manage long-term risks.

Complications

• Rapid progression to acute kidney injury or kidney failure.
• Chronic kidney disease.
• Hypertension.
• Pulmonary hemorrhage (in anti-glomerular basement membrane disease).
• Increased risk of infections due to immunosuppressive therapy.

Lifestyle & Prevention

• Manage underlying conditions (e.g., autoimmune diseases) with prescribed medications.
• Avoid nephrotoxic substances (e.g., certain NSAIDs, contrast dyes).
• Maintain a balanced diet and stay hydrated.
• Monitor blood pressure and kidney function regularly.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden swelling, blood in urine, severe fatigue, or reduced urine output. Prompt evaluation is critical to prevent irreversible kidney damage.

Tips for Medical Coders

When coding for N00.7, ensure documentation supports the diagnosis of acute nephritic syndrome with diffuse crescentic glomerulonephritis, including clinical findings (e.g., hematuria, proteinuria) and biopsy results confirming crescentic changes. Verify that the code aligns with the specific pathological description and exclude codes for other glomerular disorders.